Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.020
-0.120 (-10.53%)
At close: Mar 9, 2026, 4:00 PM EDT
1.100
+0.080 (7.84%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Clearmind Medicine Cash Flow Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 2020 - 2017
Net Income
-3.86-5.25-8.62-6.89-3
Upgrade
Depreciation & Amortization
0.050.050.060.080.01
Upgrade
Loss (Gain) From Sale of Investments
-0.840.070.110.31-
Upgrade
Stock-Based Compensation
0.8110.831.210.68
Upgrade
Other Operating Activities
-0.85-0.592.290.33-
Upgrade
Change in Accounts Receivable
0.020.06-0.150.02-0.13
Upgrade
Change in Accounts Payable
0.08-0.2-0.620.910.28
Upgrade
Change in Other Net Operating Assets
-0.140-0.190.3-0.13
Upgrade
Operating Cash Flow
-4.73-4.86-6.3-3.72-2.29
Upgrade
Capital Expenditures
----0.01-0.03
Upgrade
Sale (Purchase) of Intangibles
-----0.16
Upgrade
Investment in Securities
-0.53-0.27---
Upgrade
Other Investing Activities
-0.010.03-0.03--0.02
Upgrade
Investing Cash Flow
-0.54-0.24-0.03-0.01-0.2
Upgrade
Long-Term Debt Issued
2.25----
Upgrade
Long-Term Debt Repaid
-0.04-0.04-0.04-0.07-
Upgrade
Net Debt Issued (Repaid)
2.21-0.04-0.04-0.07-
Upgrade
Issuance of Common Stock
0.426.311.710.585.93
Upgrade
Financing Cash Flow
2.626.2511.660.515.93
Upgrade
Foreign Exchange Rate Adjustments
0-0.01-0.04-0.02-
Upgrade
Net Cash Flow
-2.651.155.3-3.243.44
Upgrade
Free Cash Flow
-4.73-4.86-6.3-3.73-2.31
Upgrade
Free Cash Flow Per Share
-37.25-62.69---
Upgrade
Cash Interest Paid
00.0100.01-
Upgrade
Cash Income Tax Paid
0.230.310.01--
Upgrade
Levered Free Cash Flow
-3.82-3.13-0.15-0.88-1.33
Upgrade
Unlevered Free Cash Flow
-3.81-3.11-0.14-0.87-1.33
Upgrade
Change in Working Capital
-0.04-0.13-0.971.240.02
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.